Trademark Overview
On Friday, June 30, 2023, a trademark application was filed for CHEMIBIONT with the United States Patent and Trademark Office. The USPTO has given the CHEMIBIONT trademark a serial number of 98066941. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, June 27, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CHEMIBIONT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; therapeutics; pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical research and development; scientific and medical research and development; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform
